UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antineoplastic activity of GP-2250 in-vitro and in mouse xenograft models

Anti-cancer drugs, 2024-02, Vol.35 (2), p.183-189

2024

Volltextzugriff (PDF)

Taurine: new implications for an old amino acid

FEMS Microbiology Letters, 2003-09, Vol.226 (2), p.195-202

2003

Volltextzugriff (PDF)

Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

BMC cancer, 2017-03, Vol.17 (1), p.216, Article 216

2017

Volltextzugriff (PDF)

Taurolidine specifically inhibits growth of neuroblastoma cell lines in vitro

Journal of pediatric hematology/oncology, 2014-05, Vol.36 (4), p.e219-e223

2014

Volltextzugriff (PDF)

Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma

International journal of oncology, 2013-03, Vol.42 (3), p.945-956

2013

Volltextzugriff (PDF)

Taurolidine–a new drug with anti-tumor and anti-angiogenic effects

Anti-cancer drugs, 2005-10, Vol.16 (9), p.917-921

2005

Volltextzugriff (PDF)

An Evaluation of Normal Saline and Taurolidine on Intra-Abdominal Adhesion Formation and Peritoneal Fibrinolysis

The Journal of surgical research, 2008, Vol.144 (1), p.151-157

2008

Volltextzugriff (PDF)

Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins

Journal of surgical oncology, 2007-09, Vol.96 (3), p.241-248

2007

Volltextzugriff (PDF)

Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines

Investigational new drugs, 2007-08, Vol.25 (4), p.305-312

2007

Volltextzugriff (PDF)

Divergent effects of taurolidine as potential anti-neoplastic agent: Inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo

Oncology reports, 2009-08, Vol.22 (2), p.409-414

2009

Volltextzugriff (PDF)

The Tumor Suppressive Reagent Taurolidine Inhibits Growth of Malignant Melanoma—a Mouse Model

The Journal of surgical research, 2007-12, Vol.143 (2), p.372-378

2007

Volltextzugriff (PDF)

Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine

Journal of neurosurgery, 2005-06, Vol.102 (6), p.1055-1068

2005

Volltextzugriff (PDF)

Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets

Mini reviews in medicinal chemistry, 2008-05, Vol.8 (5), p.421-428

2008

Volltextzugriff (PDF)

The tumor‐suppressive reagent taurolidine is an inhibitor of protein biosynthesis

International journal of cancer, 2004-11, Vol.112 (2), p.225-230

2004

Volltextzugriff (PDF)

Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer

Cancer chemotherapy and pharmacology, 2004-09, Vol.54 (3), p.249-258

2004

Volltextzugriff (PDF)

Wound Healing Is Not Impaired in Rats Undergoing Perioperative Treatment with the Antineoplastic Agent Taurolidine

European surgical research, 2009-01, Vol.42 (2), p.91-96

2009

Volltextzugriff (PDF)

Influence of Intraperitoneal Application of Taurolidine/Heparin on Expression of Adhesion Molecules and Colon Cancer in Rats Undergoing Laparoscopy

The Journal of surgical research, 2007, Vol.137 (1), p.75-82

2007

Volltextzugriff (PDF)

Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats

Surgical endoscopy, 2005-02, Vol.19 (2), p.280-284

2005

Volltextzugriff (PDF)

Taurolidine Improves Survival by Abrogating the Accelerated Development and Proliferation of Solid Tumors and Development of Organ Metastases from Circulating Tumor Cells Released Following Surgery

The Journal of surgical research, 2001-12, Vol.101 (2), p.111-119

2001

Volltextzugriff (PDF)

The effect of Taurolidine on adherent and floating subpopulations of melanoma cells

Anti-cancer drugs, 2003-04, Vol.14 (4), p.295-303

2003

Volltextzugriff (PDF)

The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism

Anticancer research, 2002-07, Vol.22 (4), p.1959

2002

Volltextzugriff (PDF)

Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging

Bone marrow transplantation (Basingstoke), 2002-02, Vol.29 (4), p.313-319

2002

Volltextzugriff (PDF)

Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer

Prostaglandins, leukotrienes and essential fatty acids, 2003-10, Vol.69 (4), p.261-267

2003

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaAntineoplastic Agents - Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antineoplastic activity of GP-2250 in-vitro and in mouse xenograft models

Taurine: new implications for an old amino acid

Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

Taurolidine specifically inhibits growth of neuroblastoma cell lines in vitro

Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma

Taurolidine–a new drug with anti-tumor and anti-angiogenic effects

An Evaluation of Normal Saline and Taurolidine on Intra-Abdominal Adhesion Formation and Peritoneal Fibrinolysis

Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins

Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines

Divergent effects of taurolidine as potential anti-neoplastic agent: Inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo

The Tumor Suppressive Reagent Taurolidine Inhibits Growth of Malignant Melanoma—a Mouse Model

Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine

Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets

The tumor‐suppressive reagent taurolidine is an inhibitor of protein biosynthesis

Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer

Wound Healing Is Not Impaired in Rats Undergoing Perioperative Treatment with the Antineoplastic Agent Taurolidine

Influence of Intraperitoneal Application of Taurolidine/Heparin on Expression of Adhesion Molecules and Colon Cancer in Rats Undergoing Laparoscopy

Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats

Taurolidine Improves Survival by Abrogating the Accelerated Development and Proliferation of Solid Tumors and Development of Organ Metastases from Circulating Tumor Cells Released Following Surgery

The effect of Taurolidine on adherent and floating subpopulations of melanoma cells

The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism

Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging

Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer

Aktive Filter

Suchergebnisse filtern